Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 809

1.

Oleanolic acid-loaded PEGylated PLA and PLGA nanoparticles with enhanced cytotoxic activity against cancer cells.

Man DK, Casettari L, Cespi M, Bonacucina G, Palmieri GF, Sze SC, Leung GP, Lam JK, Kwok PC.

Mol Pharm. 2015 Apr 16. [Epub ahead of print]

PMID:
25881668
2.

Epidemiology of ovarian cancer in North Sardinia, Italy, during the period 1992-2010.

Tanda ET, Budroni M, Cesaraccio R, Palmieri G, Palomba G, Capobianco G, Dessole M, Dessole S, Cossu A.

Eur J Gynaecol Oncol. 2015;36(1):69-72.

PMID:
25872338
3.

Adaptive response activated by dietary cis9, trans11 conjugated linoleic acid prevents distinct signs of gliadin-induced enteropathy in mice.

Bergamo P, Palmieri G, Cocca E, Ferrandino I, Gogliettino M, Monaco A, Maurano F, Rossi M.

Eur J Nutr. 2015 Apr 4. [Epub ahead of print]

PMID:
25840667
4.

AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in melanoma treatment.

Caputo E, Miceli R, Motti ML, Taté R, Fratangelo F, Botti G, Mozzillo N, Carriero MV, Cavalcanti E, Palmieri G, Ciliberto G, Pirozzi G, Ascierto PA.

J Transl Med. 2015;13:2069. doi: 10.1186/1479-5876-13-S1-P1. No abstract available.

5.

The immune-related role of BRAF in melanoma.

Tomei S, Bedognetti D, De Giorgi V, Sommariva M, Civini S, Reinboth J, Al Hashmi M, Ascierto ML, Liu Q, Ayotte BD, Worschech A, Uccellini L, Ascierto PA, Stroncek D, Palmieri G, Chouchane L, Wang E, Marincola FM.

J Transl Med. 2015;13:2056. doi: 10.1186/1479-5876-13-S1-K19. No abstract available.

6.

Impact of tissue type and content of neoplastic cells of samples on the quality of epidermal growth factor receptor mutation analysis among patients with lung adenocarcinoma.

Paliogiannis P, Attene F, Cossu A, Defraia E, Porcu G, Carta A, Sotgiu MI, Pazzola A, Cordero L, Capelli F, Fadda GM, Ortu S, Sotgiu G, Palomba G, Sini MC, Palmieri G, Colombino M.

Mol Med Rep. 2015 Jul;12(1):187-91. doi: 10.3892/mmr.2015.3347. Epub 2015 Feb 12.

PMID:
25683726
7.

Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas.

Manca A, Lissia A, Capone M, Ascierto PA, Botti G, Caracò C, Stanganelli I, Colombino M, Sini M, Cossu A, Palmieri G.

J Transl Med. 2015 Jan 28;13:37. doi: 10.1186/s12967-015-0401-8.

8.

Effect of surgery on pancreatic tumor-dependent lymphocyte asset: modulation of natural killer cell frequency and cytotoxic function.

Iannone F, Porzia A, Peruzzi G, Birarelli P, Milana B, Sacco L, Dinatale G, Peparini N, Prezioso G, Battella S, Caronna R, Morrone S, Palmieri G, Mainiero F, Chirletti P.

Pancreas. 2015 Apr;44(3):386-93. doi: 10.1097/MPA.0000000000000288.

9.

Correlative Imaging in a Patient with Cystic Thymoma: CT, MR and PET/CT Comparison.

Romeo V, Esposito A, Maurea S, Camera L, Mainenti PP, Palmieri G, Buonerba C, Salvatore M.

Pol J Radiol. 2015 Jan 13;80:22-6. doi: 10.12659/PJR.892105. eCollection 2015.

10.

Report on incidence and mortality trends of cervical cancer in northern Sardinia, Italy.

Cossu A, Capobianco G, Budroni M, Surico D, Cesaraccio R, Tanda F, Dessole M, Dessole S, Palmieri G.

Eur J Gynaecol Oncol. 2014;35(5):544-7.

PMID:
25507424
11.

Capecitabine plus gemcitabine in thymic epithelial tumors: final analysis of a Phase II trial.

Palmieri G, Buonerba C, Ottaviano M, Federico P, Calabrese F, Von Arx C, De Maio AP, Marino M, Lalle M, Montella L, Merola C, Milella M, Bergaglio M, Di Lorenzo G, Damiano V.

Future Oncol. 2014 Nov;10(14):2141-7. doi: 10.2217/fon.14.144.

PMID:
25471029
12.

Report on incidence and mortality trends of cervical cancer in northern Sardinia, Italy.

Cossu A, Capobianco G, Budroni M, Surico D, Cesaraccio R, Tanda F, Dessole M, Dessole S, Palmieri G.

Eur J Gynaecol Oncol. 2014;35(5):544-7.

PMID:
25423701
13.

Available evidence and new biological perspectives on medical treatment of advanced thymic epithelial tumors.

Serpico D, Trama A, Haspinger ER, Agustoni F, Botta L, Berardi R, Palmieri G, Zucali P, Gallucci R, Broggini M, Gatta G, Pastorino U, Pelosi G, de Braud F, Garassino MC; TYME (TYmic MalignanciEs) Collaborative Group.

Ann Oncol. 2015 May;26(5):838-847. Epub 2014 Nov 19. Review.

14.

Determination of factors controlling the particle size and entrapment efficiency of noscapine in PEG/PLA nanoparticles using artificial neural networks.

Shalaby KS, Soliman ME, Casettari L, Bonacucina G, Cespi M, Palmieri GF, Sammour OA, El Shamy AA.

Int J Nanomedicine. 2014 Oct 23;9:4953-64. doi: 10.2147/IJN.S68737. eCollection 2014.

15.

Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013.

Ascierto PA, Grimaldi AM, Anderson AC, Bifulco C, Cochran A, Garbe C, Eggermont AM, Faries M, Ferrone S, Gershenwald JE, Gajewski TF, Halaban R, Hodi FS, Kefford R, Kirkwood JM, Larkin J, Leachman S, Maio M, Marais R, Masucci G, Melero I, Palmieri G, Puzanov I, Ribas A, Saenger Y, Schilling B, Seliger B, Stroncek D, Sullivan R, Testori A, Wang E, Ciliberto G, Mozzillo N, Marincola FM, Thurin M.

J Transl Med. 2014 Oct 28;12:277. doi: 10.1186/s12967-014-0277-z.

16.

The role of immunotherapy in solid tumors: report from the Campania Society of Oncology Immunotherapy (SCITO) meeting, Naples 2014.

Ascierto PA, Addeo R, Cartenì G, Daniele B, De Laurentis M, Ianniello GP, Morabito A, Palmieri G, Pepe S, Perrone F, Pignata S, Montesarchio V.

J Transl Med. 2014 Oct 21;12(1):291.

17.

Use of in-die powder densification parameters in the implementation of process analytical technologies for tablet production on industrial scale.

Cespi M, Perinelli DR, Casettari L, Bonacucina G, Caporicci G, Rendina F, Palmieri GF.

Int J Pharm. 2014 Dec 30;477(1-2):140-7. doi: 10.1016/j.ijpharm.2014.10.009. Epub 2014 Oct 7.

PMID:
25304091
18.

ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy.

Palomba G, Atzori F, Budroni M, Ombra M, Cossu A, Sini M, Pusceddu V, Massidda B, Frau B, Notari F, Ionta M, Palmieri G.

J Transl Med. 2014 Sep 25;12:272. doi: 10.1186/s12967-014-0272-4.

19.

Efficacy of aerosol therapy of lung cancer correlates with EGFR paralysis induced by AvidinOX-anchored biotinylated Cetuximab.

De Santis R, Rosi A, Anastasi AM, Chiapparino C, Albertoni C, Leoni B, Pelliccia A, Santapaola D, Carollo V, Marra E, Aurisicchio L, Arseni B, Pacello ML, Palmieri G, Battella S, Petronzelli F, Milazzo FM.

Oncotarget. 2014 Oct 15;5(19):9239-55.

20.

Could albumin affect the self-assembling properties of a block co-polymer system and drug release? An in-vitro study.

Perinelli DR, Bonacucina G, Pucciarelli S, Cespi M, Casettari L, Polzonetti V, Carpi FM, Palmieri GF.

Pharm Res. 2015 Mar;32(3):1094-104. doi: 10.1007/s11095-014-1521-1. Epub 2014 Sep 19.

PMID:
25236343
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk